207 related articles for article (PubMed ID: 33254255)
41. Pathogenesis of ankylosing spondylitis and reactive arthritis.
Kim TH; Uhm WS; Inman RD
Curr Opin Rheumatol; 2005 Jul; 17(4):400-5. PubMed ID: 15956835
[TBL] [Abstract][Full Text] [Related]
42. Comparison of immune checkpoint inhibitor-induced arthritis and reactive arthritis to inform therapeutic strategy.
Jensen AK; Chatzidionysiou K; Torp CK; Sørensen AS; Tenstad HB; Schäfer VS; Kostine M; Jacobsen S; Leipe J; Kragstrup TW
Biomed Pharmacother; 2022 Apr; 148():112687. PubMed ID: 35228067
[TBL] [Abstract][Full Text] [Related]
43. Role of TNFRp55 in Yersinia enterocolitica O:3-induced arthritis: triggering bacterial antigens and articular immune response.
Di Genaro MS; Cargnelutti DE; Eliçabe JR; Lacoste MG; Valdez S; Gómez N; de Guzmán AM
Rheumatology (Oxford); 2007 Apr; 46(4):590-6. PubMed ID: 17043042
[TBL] [Abstract][Full Text] [Related]
44. [History of reactive arthritis. Historical milestones and future].
Zeidler H
Z Rheumatol; 2022 Oct; 81(8):692-698. PubMed ID: 36006472
[TBL] [Abstract][Full Text] [Related]
45. Reactive arthritis following COVID-19: clinical case presentation and literature review.
Bekaryssova D; Yessirkepov M; Bekarissova S
Rheumatol Int; 2024 Jan; 44(1):191-195. PubMed ID: 37801125
[TBL] [Abstract][Full Text] [Related]
46. Expanding the spectrum of spondyloarthritis (SpA): post-streptococcal reactive arthritis (PSRA)-related psoriatic spondyloarthritis (PSpA).
Vega-Villanueva KI; Espinoza LR
Clin Rheumatol; 2019 Sep; 38(9):2363-2365. PubMed ID: 31388811
[No Abstract] [Full Text] [Related]
47. Clostridium difficile associated reactive arthritis: Case report and literature review.
Legendre P; Lalande V; Eckert C; Barbut F; Fardet L; Meynard JL; Surgers L
Anaerobe; 2016 Apr; 38():76-80. PubMed ID: 26743187
[TBL] [Abstract][Full Text] [Related]
48. Reactive arthritis.
Petersel DL; Sigal LH
Infect Dis Clin North Am; 2005 Dec; 19(4):863-83. PubMed ID: 16297737
[TBL] [Abstract][Full Text] [Related]
49. HLA-B27 negative reactive arthritis versus HLA-B27 positive reactive arthritis: A retrospective study.
Ding Y; Xue L
Medicine (Baltimore); 2022 Sep; 101(35):e30383. PubMed ID: 36107557
[TBL] [Abstract][Full Text] [Related]
50. Reactive arthritis: a paradigm for inflammatory arthritis.
Kingsley GH
Clin Exp Rheumatol; 1993; 11 Suppl 8():S29-36. PubMed ID: 8324948
[TBL] [Abstract][Full Text] [Related]
51. Current perspectives in reactive arthritis.
Kingsley G; Sieper J
Immunol Today; 1993 Aug; 14(8):387-91. PubMed ID: 8397777
[TBL] [Abstract][Full Text] [Related]
52. Potential triggering infections of reactive arthritis.
Butrimiene I; Ranceva J; Griskevicius A
Scand J Rheumatol; 2006; 35(6):459-62. PubMed ID: 17343254
[TBL] [Abstract][Full Text] [Related]
53. Reactive arthritis: newer developments.
Flores D; Marquez J; Garza M; Espinoza LR
Rheum Dis Clin North Am; 2003 Feb; 29(1):37-59, vi. PubMed ID: 12635499
[TBL] [Abstract][Full Text] [Related]
54. Reactive arthritis associated with group C and group G beta-hemolytic streptococci.
Jansen TL; Janssen M; de Jong AJ
J Rheumatol; 1998 Jun; 25(6):1126-30. PubMed ID: 9632075
[TBL] [Abstract][Full Text] [Related]
55. Outcomes and Safety of Tumor Necrosis Factor Inhibitors in Reactive Arthritis: A Nationwide Experience from Iceland.
Thorsteinsson B; Geirsson AJ; Krogh NS; Gudbjornsson B;
J Rheumatol; 2020 Oct; 47(10):1575-1581. PubMed ID: 32007931
[TBL] [Abstract][Full Text] [Related]
56. HLA-B27 and host-pathogen interaction.
Sahlberg AS; Granfors K; Penttinen MA
Adv Exp Med Biol; 2009; 649():235-44. PubMed ID: 19731633
[TBL] [Abstract][Full Text] [Related]
57. [Mucocutaneous abnormalities in Chlamydia trachomatis-induced reactive arthritis].
Quint KD; van der Helm-van Mil AH; Bergman W; Lavrijsen AP
Ned Tijdschr Geneeskd; 2010; 154():A1614. PubMed ID: 20699017
[TBL] [Abstract][Full Text] [Related]
58. Host risk factors for the development of reactive arthritis: a family study.
Thomson GT; Minenko A; Schroeder ML
J Rheumatol; 1993 Aug; 20(8):1350-2. PubMed ID: 8230017
[TBL] [Abstract][Full Text] [Related]
59. Reactive arthritis after COVID-19 infection.
Ono K; Kishimoto M; Shimasaki T; Uchida H; Kurai D; Deshpande GA; Komagata Y; Kaname S
RMD Open; 2020 Aug; 6(2):. PubMed ID: 32763956
[TBL] [Abstract][Full Text] [Related]
60. Neutrophils of healthy subjects with a history of reactive arthritis show enhanced responsiveness, as defined by CD11b expression in adherent and non-adherent whole blood cultures.
Kuuliala K; Orpana A; Leirisalo-Repo M; Repo H
Rheumatology (Oxford); 2007 Jun; 46(6):934-7. PubMed ID: 17384172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
